Skip to main content
Fig. 1 | Allergy, Asthma & Clinical Immunology

Fig. 1

From: Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi

Fig. 1

Clinical course of the patient from the time of diagnosis of eosinophilic granulomatosis with polyangiitis to the time of heart failure. AZP azathioprine, CyA cyclosporine A, Eo eosinophil, FFP formoterol fluticasone combination, FP fluticasone propionate, HFA hydrofluoroalkane, ICS inhaled corticosteroid, IVCY intravenous cyclophosphamide, IVIG intravenous immunoglobulin, MPO-ANCA myeloperoxidase-anti-neutrophil cytoplasmic antibody, mPSL methylprednisolone, PSL prednisolone, WBC white blood cell count

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us